| Issue Date | Title | Author(s) |
| 2015 | Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunction | Denisiuk, T. A.; Demchenko, S. A.; Saroyan, K. V. |
| 2015 | Endothelio- and cardioprotective effects of HMG-CoA reductase inhibitors under the condition of endotoxin-induced endothelial dysfunction | Denisuk, T. A.; Pokrovskii, M. V.; Philippova, O. V.; Dolzhikov, A. A.; Pokrovskaia, T. G.; Korokin, M. V.; Gudyrev, O. S. |
| 2016 | Endothelioprotective property of the combination of the thioctic acid and rosuvastatin shown in the endothelial dysfunction models | Molchanova, O. V.; Pokrovskaya, T. G.; Povetkin, S. V.; Reznikov, K. M. |
| 2016 | Endothelium and cardioprotective effects of hmg-co-a-reductase in combination with l-arginine In endothelial dysfunction modeling | Denisyuk, T. A.; Lazareva, G. A.; Provotorov, V. Y.; Shaposhnikov, A. A. |
| 2018 | Forming statin response in patients with coronary heart disease in presence of acute respiratory viral infections by means of genetic markers | Mal, G. S.; Gribovskaya, I. A. |
| 2023 | Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease | Kononov, S.; Azarova, L.; Klyosova, E.; Bykanova, M.; Churnosov, M. |
| 2022 | Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk | Kononova, S.; Mal, G.; Azarova, I.; Klyosova, E.; Bykanova, M.; Churnosov, M.; Polonikov, A. |
| 2015 | Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients | Polonikov, A.; Zvyagina, M.; Krivoshei, I.; Sirotina, S.; Churnosov, M. |
| 2018 | Pharmacological correction of experimental osteoporosis and fractures related to it by means of rosuvastatin, L-norvaline and their combination | Sobolev, M. S.; Faitelson, A. V.; Rajkumar, D. S. R. |
| 2018 | Study of endothelio- and osteoprotective effects of combination of rosuvastatin with L-norvaline in experiment | Sobolev, M. S.; Faitelson, A. V.; Gudyrev, O. S.; Rajkumar, D.S.R.; Dubrovin, G. M. |
| 2016 | Study of the influence of L-norvaline, rosuvastatin and their combination on the level of microcirculation in bone tissue in experimental osteoporosis and fractures on its background | Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Stepchenko, A. A.; Dolzhikov, A. A. |
| 2015 | Study of the microcirculation level in bone with osteoporosis and osteoporotic fractures during therapy with recombinant erythropoietin, rosuvastatin and their combinations | Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Pokrovskii, M. V. |
| 2015 | Study of the microcirculation level in bone with osteoporosis and osteoporotic fractures during therapy with recombinant erythropoietin, rosuvastatin and their combinations | Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Pokrovskii, M. V. |
